Product NDC: | 63323-201 |
Proprietary Name: | Lidocaine |
Non Proprietary Name: | LIDOCAINE HYDROCHLORIDE |
Active Ingredient(s): | 10 mg/mL & nbsp; LIDOCAINE HYDROCHLORIDE |
Administration Route(s): | INFILTRATION; PERINEURAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 63323-201 |
Labeler Name: | APP Pharmaceuticals, LLC |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA080404 |
Marketing Category: | ANDA |
Start Marketing Date: | 20100527 |
Package NDC: | 63323-201-02 |
Package Description: | 25 VIAL in 1 TRAY (63323-201-02) > 2 mL in 1 VIAL |
NDC Code | 63323-201-02 |
Proprietary Name | Lidocaine |
Package Description | 25 VIAL in 1 TRAY (63323-201-02) > 2 mL in 1 VIAL |
Product NDC | 63323-201 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | LIDOCAINE HYDROCHLORIDE |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INFILTRATION; PERINEURAL |
Start Marketing Date | 20100527 |
Marketing Category Name | ANDA |
Labeler Name | APP Pharmaceuticals, LLC |
Substance Name | LIDOCAINE HYDROCHLORIDE |
Strength Number | 10 |
Strength Unit | mg/mL |
Pharmaceutical Classes | Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Antiarrhythmic [EPC],Local Anesthesia [PE] |